Introduction
The present report deals with the levels of fibrin degradation products (F.D.P.) found in normal pregnancy and parturition and in patients with complications of pregnancy; F.D.P. levels may reflect fibrinolysis occurring in vivo in response to intravascular fibrin deposition. According to present knowledge a physiological balance between the blood coagulation and fibrinolytic mechanisms may exist which maintains an intact patent vascular tree, the coagulation system laying down fibrin on the vascular endothelium to seal any gaps which may occur and the fibrinolytic system removing such fibrinous deposits after they have served their haemostatic function. An imbalance in these mechanisms therefore might be expected in one set of circumstances-that is, diminished coagulability or excessive fibrinolysis-to lead to failure of haemostasis ; alternatively, hypercoagulability and defective fibrinolysis might predispose to vascular occlusion.
In the blood coagulation system the inactive plasma protein prothrombin is converted by thromboplastin to thrombin, which in turn brings about the conversion of the soluble protein fibrinogen to insoluble fibrin. The fibrinolytic system has a similar basic structure ; plasminogen, an inert plasma globulin, is converted by activators to plasmin, a proteolytic enzyme which digests fibrin and releases soluble smaller molecular weight fragments of this protein (F.D.P. and to inhibit both fibrin polymerization (Fletcher, 1966) and the aggregation of platelets Wilson et al., 1968) In patients who had a prolonged thrombin clotting-time (McNicol and Douglas, 1964 ) the test serum was incubated for two hours at 370 C. with about one-tenth of its volume of thrombin (100 units/ml.) to remove any residual thrombinclottable fibrinogen. In the test samples where raised levels were found the assay was repeated after further incubation with thrombin, so that so far as was possible only immunological reactive products which were not clottable by thrombin were estimated.
Plasminogen Assay.-The method of Remmert and Cohen (1949) Ratnoff and Menzie (1965) .
Euglobulin Lysis Time.-The test was carried out by the method described by Nilsson and Olow (1962) .
Platelet Count.-A direct count was performed on venous blood as described by Dacie and Lewis (1963) .
Results
The results of the assay for F.D.P. in the serum during pregnancy, labour, and the puerperium in the 250 patients are shown in Fig. 1 . No significant alteration of the level took place during normal pregnancy until the first stage of labour, when the mean level rose to 35+28 ,ug./ml., a highly significant rise (t=4 555, P<0 001). A further increase in the mean level was found during the first week of the puerperium; by the sixth week after delivery the mean serum level had returned to 19+17 /tg./ml.
In the 12 patients studied after caesarean operations the levels of F.D.P. two to four hours after operation were in the range 1 6-20 2 ftg./ml. (mean 7-2 ttg./ml.). Samples from the same 12 patients taken three to eight days after operation were in the range 1-6-108 tsg.lml. (mean 17 9 /ig./ml.), a significant rise (0 01<P<0 05). The levels of F.D.P. were thus sub- The levels of serum F.D.P. found in the obstetric complications studied are shown in Fig. 2 , and the mean levels found in the 250 healthy women during normal pregnancy, labour, and the puerperium are included for comparison. As shown in Fig. 2 raised amounts of F.D.P. were found in each complication, and substantial levels were detected in the sera of the patients with abruptio placentae. Serial observations made in these cases of abruptio placentae showed that the level of F.D.P. may increase rapidly during labour, but after delivery the level sharply decreased, indicating that the degradation products are quickly eliminated from the circulation (Fig. 3) . In the patient with abruptio placentae shown in Fig. 3 urine assay for F.D.P. when the serum level was 1,280 .g./ml.
showed a level of 40 ,tg./ml., suggesting that a small proportion of the degradation products may be excreted in the urine. Reduced fibrinogen levels were present in all but one of the patients with abruptio placentae. In the two patients with eclampsia in late pregnancy the F.D.P. level in the serum rose steeply over the 48 hours after the eclamptic seizures. The findings in one of these patients are shown in Fig. 4 . The euglobulin lysis time was consistently prolonged, indicating low levels of plasminogen activator in the circulating plasma ; the plasminogen and fibrinogen levels were also depressed; the serum F.D.P. rose from 2 5 to 60 jig./ml. over the four days after the eclamptic seizures, and during this period of platelet count was depressed. 
Discussion
In normal pregnancy an increased concentration of fibrinogen and the coagulation factors VII, VIII, and X has been reported (Pechet and Alexander, 1961; Talbert and Langdell, 1964; Nilsson and Kullander, 1967) , and in late pregnancy and labour a marked reduction of fibrinolytic activity has been found (Bonnar et al., 1969 (Fox, 1963 ; Devi et al., 1968 MacKay et al., 1967) , and uterine action during labour is accompanied by transient myometrial ischaemia. Circumstances therefore may exist for the local release of activator, and this may then be absorbed on placental fibrin with consequent local fibrinolytic activity in the placental circulation. An enhanced fibrinolytic activity in the uterine circulation during labour could be a natural defence mechanism to maintain the maternal blood supply to the placenta by ensuring the patency of the placental bed during labour.
The raised levels of F.D.P. in the puerperium after normal delivery are possibly related to the removal of fibrin laid down to secure haemostasis in the uterus after separation of the placenta. The higher levels found after delivery by caesarean section may possibly reflect the more extensive tissue damage associated with operative delivery.
With the exception of one patient with abruptio placentae who had transient evidence of a proteolytic state the high levels of F.D.P. in abruptio placentae and after eclampsia were present in association with greatly diminished lytic activity in the circulation. This suggests that the abnormal amounts of degradation products in the serum are most likely the result of localized lysis of fibrin in the vascular compartment rather than proteolysis of circulating fibrinogen. The raised levels of F.D.P. may therefore indicate that in these complications of pregnancy both intravascular fibrin formation and fibrin proteolysis are taking place.
The placenta and decidua were observed by Seegers and Schneider (1951) to be particularly rich in clot-promoting substance, and in pregnant women dying soon after abruptio placentae emboli of fibrin-like material have been found in the pulmonary arterioles and in other organs (Schneider, 1951; Mayer et al., 1954; Johnstone and McCallum, 1956; Beischer, 1961) . In animal experiments Brown and Stalker (1968) demonstrated that after induced premature separation of the placenta white emboli resembling fibrin emboli were released from the placental bed into the maternal and foetal circulations. The activation of the plasminogen system is therefore likely to be a direct or indirect protective response to intravascular clotting.
High levels of degradation products of fibrin would also be in accord with the concept that lysis of intravascular fibrin is due to local activation of plasminogen within the thrombi (Sherry et al., 1959) . The reduced levels of plasminogen activator in pregnancy (Shaper et al., 1965 ; Nilsson and Kullander, 1967; Bonnar et al., 1969) may be important in the pathogenesis of such conditions as acute tubular necrosis in association with severe placental abruption, as low levels of activator could delay the removal of intravascular fibrin in the renal ciTrculation; animal studies have shown that the level of plasminogen activator in the endotheliurn of renal vessels is decreased during pregnancy (Epstein, 1966 (McKay, 1966) . McKay (1965) has postulated that in pre-eclampsia low-grade intravascular coagulation is present and that the convulsions are the result of sudden agglutination of platelets and the formation of platelet and fibrin thrombi which obstruct the cerebral microcirculation. The findings in the two patients currently presented would be consistent with such a course of events. Foetal death in utero is followed by a gradual depletion of clotting factors (Pritchard and Ratnoff, 1955) . Intravascular coagulation has been widely incriminated as the usual cause of fibrinogen depletion in patients with a retained dead foetus (Pritchard, 1959; Hardisty and Ingram, 1965) . The report of Lerner et al. (1967) that the depleted coagulation factors after intrauterine death were corrected by the administration of heparin alone, without blood or fibrinogen, and our findings of raised serum F.D.P. after intrauterine death are strong evidence that intravascular coagulation is the mechanism responsible for the depletion of the clotting factors.
The levels of F.D.P. were only slightly raised in the patients with post-partum haemorrhage, in contrast to the patients with abruptio placentae, in whom very high levels were found. Hardaway (1966) has shown experimentally in dogs that haemorrhagic shock is associated with intravascular clotting if hypotension occurs in association with circumstances which favour clotting, such as high levels of coagulation factors. The presence of fibrin thrombi in the pituitary was noted by Sheehan and Murdoch (1938) in their extensive report on necrosis of the anterior pituitary in patients dying after haemorrhagic collapse at delivery. The rapid restoration of the blood volume and correction of hypotension probably limits the progression of intravascular fibrin formation and may explain the rarity of Sheehan's syndrome following post-partum haemorrhage in modem obstetric practice.
The demonstration in this investigation of abnormal amounts of fibrinolytic degradation products suggests that intravascular fibrin deposition and fibrinolysis are occurring in varying degrees in normal parturition and in abruptio placentae, intrauterine death, eclampsia, and post-partum haemorrhage. The clinical outcome in these complications of pregnancy probably depends on the balance between clotting and lysis as the condition evolves, but both thrombotic vascular occlusion and defective haemostasis are possible sequelae.
